<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02482610</url>
  </required_header>
  <id_info>
    <org_study_id>2015H0088B</org_study_id>
    <nct_id>NCT02482610</nct_id>
  </id_info>
  <brief_title>Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat</brief_title>
  <official_title>Regulation of Postprandial Nitric Oxide Bioavailability and Vascular Function By Dairy Fat</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiovascular disease (CVD) is the leading cause of death in the United States. Short-term
      increases in blood sugar, or postprandial hyperglycemia (PPH), affect blood vessel function
      and increase the risk of CVD. Greater intakes of dairy foods have been associated with a
      lower risk of CVD, but whether these effects occur directly or indirectly by displacing foods
      in the diet that might increase CVD risk is unclear. Further controversial is the extent to
      which dietary fat derived from dairy foods regulate the risk of CVD. The health benefits of
      dairy on CVD risk are at least partly attributed to its ability to limit PPH and resulting
      PPH-mediated responses leading to vascular dysfunction. This provides rationale to
      investigate full-fat containing dairy as a dietary strategy to reduce PPH and risk for heart
      disease. The objective of this project is to define the extent to which full-fat dairy milk
      compared to non-fat dairy milk protects against PPH-induced vascular dysfunction by reducing
      oxidative stress responses that limit nitric oxide bioavailability to the vascular
      endothelium in adults with prediabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study consists of three, 3-hour postprandial trials in response to consuming the
      following dietary treatments: 1. oral glucose challenge, 2. oral glucose challenge in
      combination with non-fat milk, and 3. oral glucose challenge in combination with whole milk.
      For three days preceding each trial, participants will be provided all meals to standardize
      physiologic responses to test meals. On each trial day, vascular function will be assessed
      and blood samples collected prior to and at 30 minute intervals for 3 hours following test
      meal ingestion.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Actual">March 2018</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular Endothelial Function</measure>
    <time_frame>Area under curve of FMD for three hours (0, 30, 60, 90, 120, 150, and 180 min)</time_frame>
    <description>Flow mediated dilation (FMD) evaluated on the basis as change from baseline to calculate FMD area under the curve from 0-180 min, i.e. i.e. Area Under the Curve (AUC) of change from baseline in FMD from 0 min to 180 min (i.e., AUC (FMD 0 min- 0 min, FMD 30 min-0 min, FMD 60 min-0 min, etc)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomarker of Nitric Oxide Homeostasis (NOx)</measure>
    <time_frame>Area under curve of nitrite/nitrate for three hours (0, 30, 60, 90, 120, 150, and 180 min)</time_frame>
    <description>Biomarker of nitric oxide homeostasis is based on the assessment of total nitrite and nitrate concentrations. Changes relative to baseline were used to calculate area under the curve of total nitric oxide metabolites from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in nitric oxide homeostasis from 0 min to 180 min (i.e., AUC (NOx 0 min- 0 min, NOx 30 min-0 min, NOx 60 min-0 min, etc)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>Area under curve of glucose for three hours (0, 30, 60, 90, 120, 150, and 180 min)</time_frame>
    <description>Glucose concentrations evaluated on the basis as change from baseline to calculate glucose area under the curve from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in glucose from 0 min to 180 min (i.e., AUC (glucose 0 min- 0 min, glucose 30 min-0 min, glucose 60 min-0 min, etc)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative Stress Biomarker (Malondialdehyde; MDA)</measure>
    <time_frame>Area under curve of MDA for three hours (0, 30, 60, 90, 120, 150, 180 min)</time_frame>
    <description>MDA concentrations evaluated on the basis as change from baseline to calculate MDAarea under the curve from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in MDA from 0 min to 180 min (i.e., AUC (MDA 0 min- 0 min, MDA 30 min-0 min, MDA 60 min-0 min, etc)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Prediabetes</condition>
  <arm_group>
    <arm_group_label>Glucose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose with Whole Fat Milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose with Non-fat Milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose</intervention_name>
    <description>Following baseline measurements, participants will consume a 75 g glucose solution within five minutes.</description>
    <arm_group_label>Glucose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose with Whole Fat Milk</intervention_name>
    <description>Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
    <arm_group_label>Glucose with Whole Fat Milk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose with Non-fat Milk</intervention_name>
    <description>Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
    <arm_group_label>Glucose with Non-fat Milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. hemoglobin A1c 5.7-6.4%

          2. non-dietary supplement user

          3. no medications affecting vasodilation, inflammation, or energy metabolism

          4. no CVD

          5. nonsmokers

          6. individuals having blood pressure &lt;140/90 mmHg and total cholesterol &lt;240 mg/dL

        Exclusion Criteria:

          1. unstable weight (±2 kg)

          2. vegetarian or dairy allergy

          3. alcohol intake &gt;3 drinks/day or &gt;10 drinks/week

          4. ≥ 7 hours/week of aerobic activity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard S Bruno, PhD, RD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17. Erratum in: Circulation. 2015 Jun 16;131(24):e535. Circulation. 2016 Feb 23;133(8):e417.</citation>
    <PMID>25520374</PMID>
  </reference>
  <reference>
    <citation>DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001 Feb 12;161(3):397-405.</citation>
    <PMID>11176766</PMID>
  </reference>
  <reference>
    <citation>Ballard KD, Bruno RS. Protective role of dairy and its constituents on vascular function independent of blood pressure-lowering activities. Nutr Rev. 2015 Jan;73(1):36-50. doi: 10.1093/nutrit/nuu013. Review.</citation>
    <PMID>26024056</PMID>
  </reference>
  <reference>
    <citation>Ballard KD, Mah E, Guo Y, Pei R, Volek JS, Bruno RS. Low-fat milk ingestion prevents postprandial hyperglycemia-mediated impairments in vascular endothelial function in obese individuals with metabolic syndrome. J Nutr. 2013 Oct;143(10):1602-10. doi: 10.3945/jn.113.179465. Epub 2013 Aug 21.</citation>
    <PMID>23966328</PMID>
  </reference>
  <results_reference>
    <citation>McDonald JD, Mah E, Chitchumroonchokchai C, Dey P, Labyk AN, Villamena FA, Volek JS, Bruno RS. Dairy milk proteins attenuate hyperglycemia-induced impairments in vascular endothelial function in adults with prediabetes by limiting increases in glycemia and oxidative stress that reduce nitric oxide bioavailability. J Nutr Biochem. 2019 Jan;63:165-176. doi: 10.1016/j.jnutbio.2018.09.018. Epub 2018 Sep 25.</citation>
    <PMID>30412905</PMID>
  </results_reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>June 24, 2015</study_first_submitted>
  <study_first_submitted_qc>June 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2015</study_first_posted>
  <results_first_submitted>March 28, 2018</results_first_submitted>
  <results_first_submitted_qc>April 2, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 29, 2019</results_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Richard Bruno</investigator_full_name>
    <investigator_title>Professor and Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Dairy</keyword>
  <keyword>Milk</keyword>
  <keyword>Glucose</keyword>
  <keyword>Postprandial</keyword>
  <keyword>Hyperglycemia</keyword>
  <keyword>Prediabetes</keyword>
  <keyword>Blood glucose</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Vascular health</keyword>
  <keyword>Vascular function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 25, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/10/NCT02482610/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Glucose, Then Glucose +Non-fat Milk, Then Glucose + Whole Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
        </group>
        <group group_id="P2">
          <title>Glucose, Then Glucose + Whole Milk, Then Glucose +Non-fat Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
        </group>
        <group group_id="P3">
          <title>Glucose +Non-fat Milk, Then Glucose + Whole Milk, Then Glucose</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.</description>
        </group>
        <group group_id="P4">
          <title>Glucose +Non-fat Milk, Then Glucose, Then Glucose + Whole Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
        </group>
        <group group_id="P5">
          <title>Glucose + Whole Milk, Then Glucose, Then Glucose +Non-fat Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
        </group>
        <group group_id="P6">
          <title>Glucose + Whole Milk, Then Glucose +Non-fat Milk, Then Glucose</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Study Participants</title>
          <description>Participants who were randomized to receive either Glucose, Glucose + Whole Fat Milk, or Glucose + Non-fat Milk. All participants received all three treatments in a randomized order.
Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose + Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose + Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.7" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.6" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Waist Circumference</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107.7" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125.4" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="82.7" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting Glucose</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="109.8" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total Cholesterol</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="177.7" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Carotid Artery Intima Media Thickness (cIMT) (left)</title>
          <description>cIMT was assessed as a potential co-variate by measuring cIMT using ultrasonography</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".59" spread=".01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Carotid Artery Intima Media Thickness (cIMT) (right)</title>
          <description>cIMT was assessed as a potential co-variate by measuring cIMT using ultrasonography</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value=".59" spread=".01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Vascular Endothelial Function</title>
        <description>Flow mediated dilation (FMD) evaluated on the basis as change from baseline to calculate FMD area under the curve from 0-180 min, i.e. i.e. Area Under the Curve (AUC) of change from baseline in FMD from 0 min to 180 min (i.e., AUC (FMD 0 min- 0 min, FMD 30 min-0 min, FMD 60 min-0 min, etc)</description>
        <time_frame>Area under curve of FMD for three hours (0, 30, 60, 90, 120, 150, and 180 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glucose</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants will consume a 75 g glucose solution within five minutes.</description>
          </group>
          <group group_id="O2">
            <title>Glucose With Whole Fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
          </group>
          <group group_id="O3">
            <title>Glucose With Non-fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Vascular Endothelial Function</title>
          <description>Flow mediated dilation (FMD) evaluated on the basis as change from baseline to calculate FMD area under the curve from 0-180 min, i.e. i.e. Area Under the Curve (AUC) of change from baseline in FMD from 0 min to 180 min (i.e., AUC (FMD 0 min- 0 min, FMD 30 min-0 min, FMD 60 min-0 min, etc)</description>
          <units>%*min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-195.9" spread="35.99"/>
                    <measurement group_id="O2" value="-6.181" spread="47.2"/>
                    <measurement group_id="O3" value="-5.629" spread="36.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Biomarker of Nitric Oxide Homeostasis (NOx)</title>
        <description>Biomarker of nitric oxide homeostasis is based on the assessment of total nitrite and nitrate concentrations. Changes relative to baseline were used to calculate area under the curve of total nitric oxide metabolites from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in nitric oxide homeostasis from 0 min to 180 min (i.e., AUC (NOx 0 min- 0 min, NOx 30 min-0 min, NOx 60 min-0 min, etc)</description>
        <time_frame>Area under curve of nitrite/nitrate for three hours (0, 30, 60, 90, 120, 150, and 180 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glucose</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants will consume a 75 g glucose solution within five minutes.</description>
          </group>
          <group group_id="O2">
            <title>Glucose With Whole Fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
          </group>
          <group group_id="O3">
            <title>Glucose With Non-fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarker of Nitric Oxide Homeostasis (NOx)</title>
          <description>Biomarker of nitric oxide homeostasis is based on the assessment of total nitrite and nitrate concentrations. Changes relative to baseline were used to calculate area under the curve of total nitric oxide metabolites from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in nitric oxide homeostasis from 0 min to 180 min (i.e., AUC (NOx 0 min- 0 min, NOx 30 min-0 min, NOx 60 min-0 min, etc)</description>
          <units>umol/L*min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2229" spread="343.3"/>
                    <measurement group_id="O2" value="-1240" spread="252.7"/>
                    <measurement group_id="O3" value="-1221" spread="228.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glucose</title>
        <description>Glucose concentrations evaluated on the basis as change from baseline to calculate glucose area under the curve from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in glucose from 0 min to 180 min (i.e., AUC (glucose 0 min- 0 min, glucose 30 min-0 min, glucose 60 min-0 min, etc)</description>
        <time_frame>Area under curve of glucose for three hours (0, 30, 60, 90, 120, 150, and 180 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glucose</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants will consume a 75 g glucose solution within five minutes.</description>
          </group>
          <group group_id="O2">
            <title>Glucose With Whole Fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
          </group>
          <group group_id="O3">
            <title>Glucose With Non-fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Glucose</title>
          <description>Glucose concentrations evaluated on the basis as change from baseline to calculate glucose area under the curve from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in glucose from 0 min to 180 min (i.e., AUC (glucose 0 min- 0 min, glucose 30 min-0 min, glucose 60 min-0 min, etc)</description>
          <units>mg/dL*min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6259" spread="622.5"/>
                    <measurement group_id="O2" value="4481" spread="652.4"/>
                    <measurement group_id="O3" value="3408" spread="574.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oxidative Stress Biomarker (Malondialdehyde; MDA)</title>
        <description>MDA concentrations evaluated on the basis as change from baseline to calculate MDAarea under the curve from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in MDA from 0 min to 180 min (i.e., AUC (MDA 0 min- 0 min, MDA 30 min-0 min, MDA 60 min-0 min, etc)</description>
        <time_frame>Area under curve of MDA for three hours (0, 30, 60, 90, 120, 150, 180 min)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Glucose</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants will consume a 75 g glucose solution within five minutes.</description>
          </group>
          <group group_id="O2">
            <title>Glucose With Whole Fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
          </group>
          <group group_id="O3">
            <title>Glucose With Non-fat Milk</title>
            <description>This study day will last approximately three hours and will be separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants will consume 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Oxidative Stress Biomarker (Malondialdehyde; MDA)</title>
          <description>MDA concentrations evaluated on the basis as change from baseline to calculate MDAarea under the curve from 0-180 min, i.e. Area Under the Curve (AUC) of change from baseline in MDA from 0 min to 180 min (i.e., AUC (MDA 0 min- 0 min, MDA 30 min-0 min, MDA 60 min-0 min, etc)</description>
          <units>umol/L*min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.9" spread="7.653"/>
                    <measurement group_id="O2" value="25.78" spread="9.505"/>
                    <measurement group_id="O3" value="31.3" spread="5.283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were monitored for adverse events during the entirety of the study duration (~6 total weeks).</time_frame>
      <desc>Participants completed a cross-over trial that examined blood vessel function and related biomarkers in response to a single controlled meal. The risk for all-cause mortality relating to the study is perceived to be zero.</desc>
      <group_list>
        <group group_id="E1">
          <title>Glucose, Then Glucose +Non-fat Milk, Then Glucose + Whole Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
        </group>
        <group group_id="E2">
          <title>Glucose, Then Glucose + Whole Milk, Then Glucose +Non-fat Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
        </group>
        <group group_id="E3">
          <title>Glucose +Non-fat Milk, Then Glucose + Whole Milk, Then Glucose</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.</description>
        </group>
        <group group_id="E4">
          <title>Glucose +Non-fat Milk, Then Glucose, Then Glucose + Whole Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.</description>
        </group>
        <group group_id="E5">
          <title>Glucose + Whole Milk, Then Glucose, Then Glucose +Non-fat Milk</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.</description>
        </group>
        <group group_id="E6">
          <title>Glucose + Whole Milk, Then Glucose +Non-fat Milk, Then Glucose</title>
          <description>Each study day lasted approximately three hours and was separated from the other arms by four days for men and one month for women.
Glucose with Whole Fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of whole fat milk within five minutes.
Glucose with Non-fat Milk: Following baseline measurements, participants consumed 75 g glucose dissolved in two cups of non-fat milk within five minutes.
Glucose: Following baseline measurements, participants consumed a 75 g glucose solution within five minutes.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Richard Bruno, PhD, RD</name_or_title>
      <organization>The Ohio State University</organization>
      <phone>6142925522</phone>
      <email>bruno.27@osu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

